Inflammatory and immune responses within the central nervous system (CNS) significantly affect the clinical presentation and outcome of brain disorders, including stroke, trauma, Alzheimer's disease, Parkinson's disease, epi lepsy, encephalomyelitis, and multiple sclerosis (MS; Weiner and Selkoe, 2002) . In the case of MS and its animal model experimental auto immune encephalomyelitis (EAE), a classical inflammatory disease characterized by cellular influx, demyelination, and axonal damage of the CNS, initiation of disease is controlled by an interplay between cells of the innate and adaptive immune systems (Steinman, 1996; Wekerle, 1998) . NK cells are an important cell subset of the innate immune system represented by large granular lymphocytes that respond rapidly to a variety of insults with cytolytic ac tivity and cytokine secretion (Kärre et al., 1986; Biron et al., 1999; Yokoyama and Plougastel, 2003; Raulet, 2004; Lanier, 2008) . Recently, there has been a growing understanding of NK cells, particularly with regard to their roles in autoimmunity in the joints, pancreas, and CNS (French and Yokoyama, 2004; Shi and Van Kaer, 2006; Wu et al., 2007; Feuerer et al., 2009) . Mechanisms by which NK cells could have an impact on autoimmune responses in clude a rapid cytokine release by NK cells be fore autoreactive helper T cell differentiation and modulation of interactions between auto reactive T cells, B cells, and APCs (Chambers et al., 1996; Shi et al., 2000; MartínFontecha et al., 2004; Laouar et al., 2005) . However, much of this evidence is derived from studying peripheral lymphoid organs. Whether NK cells can act in target organs of autoimmunity such as the CNS has not yet been investigated.
The manifestations of CNS disease, such as MS and EAE, require the homing of myelin reactive T cells to the CNS, where T cells undergo reactivation, further differentiation, and expansion. The spectrum of APCs, antigens, (clone PK136) dramatically enhanced EAE severity (Zhang et al., 1997; Xu et al., 2005) . We confirmed these findings and verified that disease exacerbation was caused by the removal of NK cells rather than NKT cells (Fig. S2) . Pathologically, the mice treated with antiNK1.1 mAb exhibited pronounced cel lular infiltrates, inflammation, and demyelination, as indicated by immunohistochemical staining, bioluminescence imaging, and highfield MRI, respectively (Fig. 1 , A-C).
We considered two possibilities for the exaggerated CNS disease observed in MOGimmunized mice systemically de pleted of NK cells: (1) enhanced pathogenic T cell infiltration from the periphery to the CNS, or (2) attenuated suppressive effects of NK cells on pathogenic T cells within the CNS. To distinguish between these two possibilities, we used a model of selective NK cell deficiency in the CNS. We used mice in which the chemokine receptor Cx3cr1 gene was replaced with a cDNA encoding GFP (Jung et al., 2000) . We previously demonstrated that CX3CR1 is responsible for recruiting NK cells to the inflamed CNS in mice with EAE (Huang et al., 2006) and that Cx3cr1 GFP/GFP (Cx3cr1 / ) mice exhibit a selective deficit in NK cell homing to the CNS, whereas NK cells in other organs are not affected (Huang et al., 2006) . Pathologically, the MOGprimed Cx3cr1 / mice had fre quent hemorrhagic brain and spinal cord lesions (Huang et al., 2006) . Increased inflammation and disease activity were fur ther illustrated by neuroimaging (Fig.1, B and C) .
Collectively, these results suggest that NK cell depletion from all organ systems augments the magnitude of CNS inflammation and pathology. The finding that Cx3cr1 / mice with reduced and neuroimmune interactions within the CNS are unique (Shi and Ransohoff, 2010) , and the outcome of an immune response cannot be predicted solely by the events that occurred in the periphery. NK cells readily home to the CNS under an array of pathological circumstances (Shi and Ransohoff, 2010) . It is not known whether these NK cells are simply passive migrants or actively participate in the CNS pathogenesis.
In this paper, we investigated the role of NK cells in the CNS in shaping autoimmunity and pathology. Our findings have revealed a critical role of CNSresident NK cells in con trolling the magnitude of CNS inflammation. This observation could be exploited for therapeutic intervention in CNS disease.
RESULTS

Peripheral versus CNS-resident NK cells in shaping CNS inflammation and pathology
Studies of NK cell function in vivo have often been challeng ing because of the unavailability of mice that selectively lack NK cells (Yokoyama and Plougastel, 2003; Shi and Van Kaer, 2006) . To overcome this limitation, we have combined sev eral approaches, including NK cell-depleting mAb, interrup tion of NK cell homing, and NK cell enrichment (Fig. S1) .
To dissect the role of NK cells in the development of in flammatory and autoimmune responses in the CNS, we im munized C57BL/6 (B6) mice with myelin oligodendrocyte glycoprotein (MOG) peptide, which produces a monophasic neurological deficit resembling a form of human MS known as acute disseminated encephalomyelitis. Previously, it was dem onstrated that depletion of NK1.1 + cells by antiNK1.1 mAb isolates divided four to sixfold more frequently in NK celldepleted mice than in control mice (Fig. 2 A) . As expected, lymph node CD4 + T cells from Cx3cr1 / mice proliferated at a similar magnitude as those from WT mice, whereas CNSderived Cx3cr1 / CD4 + T cells proliferated more vigo rously (Fig. 2 A) . These results indicate that NK cells suppress CD4 + T cell proliferation and this suppression is more pro nounced in the CNS than in peripheral organs.
Next, we assessed the impact of NK cell depletion or their failure to home to the CNS on the phenotype of CD4 + T cells. Depletion of NK cells reduced MOGreactive IFN-producing Th1 cell responses in lymph node but not the CNS (Fig. 2 B) . In contrast, MOGreactive CD4 + Th17 cell responses were increased three to fivefold in the CNS of NK cell-depleted mice. Importantly, the enhancement of Th17 cell responses was almost exclusive to CD4 + T cells in the CNS (Fig. 2 B) . Quan titative (q) RTPCR for il17a transcripts using sorted CD4 + T cells confirmed this finding (Fig. 2 C) . These results of NK cell depletion were mirrored by an increase of Th17 phenotype cells in Cx3cr1 / mice (Fig. 2, B and C) . The global levels of IL17 and IFN quantified using lymph node, brain, and spi nal cord homogenates were consistent with those observed for CD4 + T cells (Fig. S3) . Depletion of NK cells also led to en hanced proliferation of CD8 + T cells in lymph nodes, but such effects were absent in the CNS (Fig. S4, A and B) . In addition, the frequency of IL17 + CD8 + T cells was minimal and did not change significantly upon NK cell depletion (Fig. S4 C) . Thus, suppression of myelinreactive CD4 + Th17 cells by NK cells is largely restricted to the CNS compartment.
CNSinfiltrating NK cells but intact peripheral NK cells exhib ited similar clinical and pathological features to NK cell-depleted animals suggests that CNS NK cells are crucial in this process.
Suppression of myelin-reactive Th17 cells by NK cells is restricted to the CNS
Autoreactive T cells, particularly the CD4 + subset, home to the CNS, reencounter myelin antigens in this location and undergo reactivation and further expansion. This process is believed to be a prerequisite step for the expression of disease in EAE and perhaps in MS. Therefore, we investigated how NK cell depletion, or failure to home to the CNS, might in fluence the capacity of CD4 + T cells to proliferate and further differentiate into Th1 or Th17 cells. Lymph node (or splenic) CD4 + T cells from mice treated with antiNK1.1 mAb di vided 1.5fold more frequently than CD4 + T cells from con trol mice (Fig. 2 A and not depicted) . CD4 + T cells from CNS affinity IL2 receptors and stimulate the proliferation of memory phenotype CD8 + T cells and NK cells (Boyman et al., 2006) . We coupled IL2 with IL2 mAb (referred to as IL2 complexes or IL2 C hereafter) and examined the effects on NK cells and other lymphocytes during EAE. During our initial experiments, we developed an injection regimen of frequency and dosage that conferred maximal expansion and IL-2-mAb complexes expand NK cells with a unique phenotype Our data using NK cell-depleting antibodies and Cx3cr1 / mice show the inhibitory function of NK cells against auto immune responses within the CNS. An alternative approach to investigate the role of NK cells in this process is to enrich these cells in vivo. Prior studies have shown that anti-IL2 mAbs (clone S4B6) guide IL2 toward cells with intermediate 
CNS-resident NK cells inhibit EAE in the presence of IL-2 complexes
We evaluated the impact of IL2 complexes on the clinical course of EAE. Compared with control mice, the onset of EAE in treated mice was delayed and neurological deficits were relatively mild (Fig. 4 A) . Accordingly, these mice also ex hibited attenuated cellular infiltrates and demyelination (Fig. 4,  D-F) . While assessing the influence of IL2 complexes on MOGreactive Th cell responses, we found that IL17 mRNA expression and protein production by lymph node cells were not significantly altered by IL2 complexes, whereas IL17 production by CD4 + T cells in the CNS was dramatically re duced (Fig. 4, G-I ). IFN-producing CD4 + T cells within the CNS were also reduced (Fig. 4 G) . Alterations for CD8 + T cell-derived IFN and IL17 were minimal (Fig. S4) .
maintenance of NK cells, with its associated disease protec tion (Table S1 and not depicted). Using this protocol, we showed that IL2 complexes were more efficient than IL2 or anti-IL2 mAb alone in expanding NK cells, both in the lymph nodes and the CNS (Fig. 3 A) . With regard to their phenotypic characteristics, NK cells from IL2 complextreated mice exhibited no dramatic alterations in the expres sion of NKG2D, Ly49D, CD244 (2B4), Ly49A, and Ly49C (not depicted), a significant upregulation of the inhibitory receptor NKG2A on NK cells in the CNS (Fig. 3 B) , and an intact capacity to produce IFN (Fig. 3 C) . IL2 complexes also increased the numbers of CD8 + T cells with a predomi nantly memory phenotype and a concurrent decrease in CD4 + T cells. CD4 + CD25 + T cells and NKT cells were also increased at varying degrees (Fig. S5) . Interactions between NK cells and microglia influence myelin-reactive Th17 cells in vivo and the importance of the NKG2A-Qa1 pathway. Naive (CD25  CD62L high CD44 low ) CD4 + T cells were sorted from lymph nodes and spleens of 2D2 mice. Subsequently, 2 × 10 5 cells were injected i.v. into MOG/CFA/PT-primed RAG1 / c / mice. Simultaneously, the same numbers of microglia from Cx3cr1 +/ (MG +/ ) and Cx3cr1 / (MG / ) mice and NK cells from the IL-2 complex-treated mice were injected into the brain as previously described (Cardona et al., 2006b ). STAT3 phosphorylation was quantified by FACS and compared in mice receiving CD4 + T cells alone or mice that also received microglia from Cx3cr1 +/ or Cx3cr1 / mice. RNA was isolated from 2D2 CD4 + cells and Ror, Ror (also know as Rorc), and Il-17a transcripts were quantified by qRT-PCR. Data represent three experiments with 15-22 mice per group each. Error bars represent the means ± SEM. P-values wre determined by an ANOVA test. For C and D, + and  denote culture with or without NK cells.
that myeloid DCs (mDCs) presenting endogenous myelin peptides preferentially polarize CD4 + T cells toward the Th17 cell lineage in a relapsing remitting EAE model (Bailey et al., 2007) . We therefore compared the capacity of microglia and several types of APCs from the CNS, either migrated to this location or resident in the CNS, in priming 2D2 MOG specific T cells. In agreement with Bailey et al. (2007) , mDCs were most potent among the CNSderived APCs, includ ing microglia, astrocytes, plasmacytoid DCs (pDCs), and CD11b + CD45 + cells (microglia and macrophages), in induc ing 2D2 T cell proliferation (Fig. 5 A) and production of IL17 (Fig. 5 B) in mice with EAE. It is of note that when these APCs were isolated from MOG/CFAprimed mice that also received antiNK1.1 mAb, their capacity to induce 2D2 cell proliferation and production of IL17 was increased (Fig. 5, A and B) . Interestingly, microglia emerged as the most potent APCs in driving Th17 cells, despite their capacity to induce 2D2 cell proliferation at levels comparable to those of mDCs (Fig. 5, A and B) . Similar results were obtained using APCs from Cx3cr1 / mice (in which homing of NK cells to the CNS is severely impaired; unpublished data).
Given that NK cells alter the cytokine microenvironment in the CNS (Fig. S3 ) and that the best defined factors that determine Th cell subset differentiation are cytokines and chemokines that are present at the initiation stage of T cell re ceptor ligation (O'Garra, 1998), we compared the capacity of the CNSderived APC to release Th17 cell-polarizing cyto kines and determined whether this process could be altered by NK cells. Similar amounts of IL1, IL6, and IL23 were pro duced by microglia and mDCs from control mice with EAE (unpublished data). Importantly, production of these cyto kines was dramatically enhanced in microglia and, to a lesser extent, mDCs when NK cells were depleted (not depicted) or failed to home to the CNS (Table I ). In contrast, the differ ences for TGF1 and IL21 release by microglia and mDCs were not significant (unpublished data). Blocking experiments indeed confirmed the importance of IL1 and IL6 for the ca pacity of microglia to prime Th17 cells (unpublished data).
To investigate the mechanism by which NK cells could influence the capacity of APCs to support Th17 cell differen tiation, we cultured naive 2D2 CD62L high cells with mDCs, pDCs, CD8 + DCs, or astrocytes in the presence or absence of NK cells. We found that these APCs, isolated from NK cell-depleted or Cx3cr1 / mice, exhibited varied capacity To assess whether NK cells mediated the protection against EAE during IL2 complex therapy, we depleted NK cells before EAE induction and IL2 complex treatment. Re moval of NK cells almost completely abolished the therapeu tic effects of IL2 complexes (Fig. 4 B) . Because antiNK1.1 mAbs remove NK cells from both periphery and CNS, we asked whether NK cells in the periphery, the CNS, or both contributed to the protective effects of IL2 complexes on EAE. For this purpose, we treated Cx3cr1 / mice with IL2 complexes upon EAE induction. The clinical features of EAE were nearly identical in Cx3cr1 / mice that received con trol IgG or IL2 complexes (Fig. 4 C) . Injection of anti NK1.1 mAb into the brain eliminated NK cells from the CNS without altering peripheral NK cells and largely abrogated the therapeutic effect of IL2 complexes (unpublished data). Thus, we conclude that the effects of IL2 complexes on EAE depend on CNSresident NK cells.
In dissecting potential contributions of other IL2R-bearing cells, we treated CD1d / mice (Mendiratta et al., 1997 ; devoid of NKT cells), CD8 / mice, and mice depleted of CD25 + cells with IL2 complexes before EAE induction. IL2 complex injection attenuated EAE in CD1d / mice and mice depleted of CD25 + cells (Fig. S6, A and B). The magnitude of the disease attenuation in these mice was simi lar to that observed in WT B6 mice (Fig. 4 A) . IL2 complexes partially lost their effectiveness against EAE in CD8 / mice ( Fig. S6 C) . Furthermore, unlike NK cells (see Fig. 6 A) CD8 + T cells did not reside in close proximity with microglia. CD8 + T cells were capable of killing microglia, albeit much less effec tively than NK cells (unpublished data). Collectively, these data indicated that NKT cells, T reg cells, and CD8 + T cells do not contribute in a significant manner to the EAE phenotype in mice receiving IL2 complexes.
NK cells condition the cytokine microenvironment in the CNS
Our finding that modulation of NK cells affects myelin reactive Th17 cells in the CNS suggested that NK cells can influence the cytokine environment in a different manner in the CNS and in the periphery. To test this possibility, we com pared the cytokine profile in these two anatomical compart ments. Lymph node culture supernatants, brain, and spinal cord homogenates from MOGimmunized mice that received anti NK1.1 mAb or from MOGimmunized Cx3cr1 / mice had a tendency for an increased expression of the Th17polarizing cytokines IL1, IL6, TGF1, and TNF, as well as the pro inflammatory chemokines MCP1, MIP1, and MCP1, as compared with controls. We observed the opposite in mice treated with IL2 complexes, and such alterations appeared to be milder in lymph nodes (Fig. S3 ).
NK cells suppress the induction of Th17 transcription factors by microglia
Our observation that NK cell-mediated inhibition of CNS inflammation and Th17 cell responses are restricted to the CNS suggested the involvement of additional players specific to the CNS. Previous studies have elegantly demonstrated or failed to home to the CNS (Table I) , we hypothesized that the interactions between NK cells and microglia determine the magnitude of CNS inflammation and myelinreactive Th17 cells. We assessed the capacity of microglia, in the pres ence or absence of NK cells, to transactivate the signature tran scription factors of the Th17 cell lineage, ROR, ROR, and STAT3 (Bettelli et al., 2006b; Yang et al., 2008; Zhou et al., to drive Th17 cell responses (Fig. 5 C) . Compared with microglia, the impact of these cells was relatively mild, and NK cells had a minimal influence on their capacity to impact Th17 cell responses (Fig. 5 C) . Similar results were obtained with prepolarized Th17 cells (unpublished data). Considering that microglia were the major source of Th17 cell-polarizing cytokines when NK cells were depleted (C, bottom) Supernatants from microglia recruit NK cells in a MCP-1-dependent manner. Chemotaxis of purified CNS-infiltrating NK cells toward chemokines produced by microglia was tested by using a transwell assay. Supernatants collected from purified microglia were stimulated with PMA and were added to the lower chambers of transwell plates. Medium only was used as a control. Anti-MCP-1 antibody or MCP-1 was added as indicated. 2 × 10 5 NK cells were added to the upper chamber. Specific migration was calculated as migration index. Bars represent means of triplicate wells from a representative of three independent experiments. Error bars represent the means ± SEM. P values were determined by a Student's t test. (D) Morphological features of microglia and their proximity to inflammatory foci when NK cells are manipulated. Cx3cr1 GFP+/ , Cx3cr1 / , and Cx3cr1 +/+ mice, with microglia labeled with GFP, were immunized with MOG/CFA. A portion of the +/ mice was treated with control IgG, anti-NK1.1 mAb, or IL-2 complexes. Brain tissues were harvested during days 12-20 after immunization. Morphological features of microglia in relation to NK cells were analyzed by confocal microscopy. Activated microglia (increased size of cell body and thickening of proximal processes) were noted at a higher prevalence in control mice. A significantly higher level of reactive oxygen species (ROS; denoting areas of inflammation) was noted in NK cell-deleted mice, whereas the IL-2 complex treatment group had a lower level of ROS compared with control mice. Representative images of three independent experiments with four mice per group each are shown. Bars, 10 µm. on the physical relationship between these two cell types. Colocalization studies revealed that NK cells resided in close proximity to microglial cells (Fig. 6 A) , whereas such prox imity was not evident between NK cells and mDCs, pDCs, or astrocytes (not depicted). Furthermore, CNSderived NK cells readily produce MIP1 (Fig. 6 B) . Among mDCs, pDCs, astrocytes, and microglia, the latter cells produced MCP1 (Fig. 6 C) . Transwell migration and blocking experi ments revealed that production of MIP1 by NK cells and MCP1 by microglia resulted in reciprocal chemoattraction of these cells (Fig. 6 C) . Additionally, a statistically significant increase was observed in the recruitment of NK cells toward supernatants from microglia, compared with astrocytes, neu rons, and other CNSinfiltrating cells (DCs, T cells, and macro phages; unpublished data). In the absence of NK cells in the CNS, microglial cells exhibited dramatic activated morphologi cal features, whereas the opposite was true when NK cells were enriched in the CNS (Fig. 6 D) .
Missing self on microglia ablates NK cell tolerance
We assessed the numerical relationship between NK cells and microglia. Although the absolute numbers of CNSresident NK cells in mice that received IL2 complexes were slightly higher than in control mice with EAE (Fig. 7 A) , the ratio of 2009), in vivo. For this purpose, we isolated microglia, as well as naive or Th17polarized 2D2 cells (Bettelli et al., 2006a) , and transferred these cells into RAG1 / c / hosts via intra cerebral and intravenous routes, respectively. Microglia from Cx3cr1 / mice and, to a lesser extent, Cx3cr1 +/ mice enhanced IL17 transcripts, together with increases in ROR, ROR, IRF4 transcripts, and STAT3 expression levels ( Fig. 5 D and not depicted) . Cotransfer of NK cells derived from CNS tissues largely ablated these effects, and this was largely dependent on perforin expression by NK cells (Fig. 5 D) because transfer of perforin / NK cells restored the capacity of microglia to promote Th17 cell expansion (Fig. 5 D) . Additionally, transfer of IFN / NK cells resulted in a tendency to reduce the effects on microglia (Fig. 5 D) . In trying to discriminate whether NK cells acted directly on Th17 cells or whether microglia acted as intermediary target cells, we considered the former possibility less likely because CNSderived NK cells did not effectively lyse Th17 pheno type cells (unpublished data).
Reciprocal chemoattraction between NK cells and microglia underlies their physical proximity
The preferential impact of NK cells on microglia, among several types of CNSderived APCs, prompted investigations and GFP + microglia (×10 6 ) that were analyzed by FACS. (B) Ratio of CNS-resident NK cells and total CNS infiltrates. P < 0.01 for comparisons of microglial cell numbers from each experimental group with that from control mice. P < 0.01 for comparisons of the ratios of CNS-derived NK cells/total infiltrates from the groups that received IL-2 C with that from the remaining groups. P < 0.05 for comparisons between groups of mice that received IgG and groups that received anti-NK1.1, or groups of Cx3cr1 / mice. (C) NK cells principally target microglia. NK cells were purified from pools of CNS tissues harvested from MOG-immunized mice treated with IL-2 complexes. Microglia, astrocytes, mDCs, and pDCs were isolated from MOG-primed Cx3cr1 +/ mice and incubated with 51 Cr. The effector (NK) and target (microglia) cells (5 × 10 4 ) were incubated at E:T ratios of 25:1 and cytolytic effects were measured in a 4-h 51 Cr-release assay, as previously described (Shi et al., 2000) . ( protected microglia from NK cell killing (Fig. 7 E) and re duced the influence of NK cells on Th17 cells (Fig. 5 D) . As expression of other types of activating and inhibitory NK cell receptors, including NKG2D, Ly49D, CD244 (2B4), Ly49A, and Ly49C, was not dramatically altered upon NK cell homing to the CNS in control and IL2 complex-treated mice immunized with CFA/MOG (unpublished data), we propose that the NKG2A-Qa1 pathway plays a dominant role in the interactions between NK cells and microglia.
Biological consequences of NK cell-microglia interactions and their dependence on myelin-reactive Th17 cells
Having determined that NK cells suppress the induction of Th17 cell-defining transcription factors that are transactivated by microglia, we sought to address whether this type of inter action between NK cells and microglia can influence the expression of EAE in a cotransfer model. During our initial experiments, we titrated the numbers of 2D2 transgenic T cells, microglia, and NK cells required to induce mild, moder ate, and severe EAE in the recipient mice (unpublished data). Because augmentation of myelinreactive Th17 cells by microglia is anticipated to exacerbate EAE, we decided to use a low number of 2D2 cells to induce mild EAE so that effects of microglia and NK cells on the phenotype of EAE in recipi ent mice could be easily detected. Transfer of 2D2 cells, along with injection of microglia, resulted in a remarkable augmen tation of EAE severity (Fig. 8 A) . In contrast, addition of NK cells largely reversed the effect of microglia, and such reversal was abrogated when Qa1 was overexpressed on microglia (Fig. 8 A) . Furthermore, the effect of NK cells expanded by IL2 complexes was dependent on the presence of perforin and, to a lesser extent, IFN, as perforin and, to a lesser ex tent, IFN-deficient NK cells lost their capacity to over come the effect of microglia on EAE (unpublished data).
CNSresident NK cells/total CNS infiltrates was 6 to 10fold higher in mice that received IL2 complexes, as compared with control mice (Fig. 7 B) . The observed inverse relation ship between the numbers of NK cells and microglia could be merely a reflection of changes in the intensity of CNS in flammation when NK cells are reduced or enriched. How ever, the physical proximity between NK cells suggested direct killing of microglia as an alternative possibility. Indeed, among mDCs, pDCs, astrocytes, and microglia, the latter cells were principal targets of NK cells in vitro (Fig. 7 C) and in vivo (Fig. 7 D) , and the efficacy of such elimination was abolished when NK cells were isolated from perforindeficient mice (Fig. 7 E) .
The lack of killing by perforindeficient NK cells sug gested that NK cells used cytolytic activity toward microglia during CNS inflammation. In addition to physical factors, loss of the selfMHC class I molecule Qa1 on activated mi croglia may render these cells key targets for NK cells. Com parisons of expression of Qa1 on APCs from control mice with EAE indicated that levels of Qa1 expression were lower on microglia than on mDCs, pDCs, and astrocytes (Fig. 7 F) . Significantly, the differences in Qa1 expression on microglia versus other APCs were greater in NK cell-depleted mice (Fig. 7 F) and in Cx3cr1 / mice immunized with CFA/ MOG (not depicted). Thus, a physical proximity, as well as a reduction in Qa1 expression, ablated NK cell tolerance to microglia, whereas other types of APCs were relatively spared (as a result of maintained Qa1 expression and a relative dis tance from NK cells).
To further investigate the receptor-ligand pathways that govern interactions between NK cells and microglia, we used two approaches. Qa1 deficiency promoted NK cell killing activity (Fig. 7 E) and diminished the effects of microglia on Th17 cells (Fig. 5 D) . Conversely, overexpression of Qa1 (A) CD4 + T cells were sorted from the lymph nodes and spleen of 2D2 transgenic mice and cultured under conditions for EAE induction (see Materials and methods). Subsequently, 2 × 10 5 cells were injected i.v. into MOG/CFA/PT-primed RAG1 / c / mice. Simultaneously, the same numbers of microglia from Cx3cr1 +/ or Cx3cr1 / mice and NK cells from the IL-2 complextreated mice were injected into the brain as previously described (Cardona et al., 2006b ). In some experiments, Qa1 was overexpressed on microglia with a lentiviral vector (see Materials and methods). Development of EAE in the recipient mice was monitored and compared. P < 0.05 after day 10 after cell transfer (Mann-Whitney U test) for comparisons between groups receiving 2D2 cells versus 2D2 cells with microglia (except for the group receiving Qa1 overexpressing microglia) and for groups receiving 2D2 cells with microglia versus 2D2 cells with microglia + NK cells. P > 0.05 (Mann-Whitney U test) at all time points for comparisons among the groups of mice receiving 2D2 cells versus 2D2 cells with microglia and NK cells and for groups receiving untransfected versus Qa1-transfected microglia. n = 8-12/group. Error bars represent the means ± SEM. (B) Anti-NK1.1 mAb fails to dramatically alter the course of EAE in IL-17-deficient mice. WT and IL-17 / mice were immunized with MOG/CFA. Groups of the immunized mice also received anti-NK1.1 mAb or control IgG (see Materials and methods) upon immunization. Development of EAE was monitored and compared. P < 0.05 after day 10 (Mann-Whiteney U test) for comparisons between IL17 +/+ mice that received anti-NK1.1 mAb and all of the other groups. P > 0.05 (Mann-Whitney U test) at all time points for comparisons among the remaining groups except for IL-17 +/+ mice that received anti-NK1.1 mAb. n = 12-15/group. Error bars represent the means ± SEM. Data from A and B are pooled from three similar experiments.
NKG2A-Qa1 interactions appeared to play a central role in interactions between NK cells and microglia. In the peripheral lymphoid organs, expression of the inhibitory re ceptor NKG2A on NK cells is induced by gene products of infectious agents, such as cytomegalovirus, and is sustained by certain cytokines (i.e., IL12 and IL10; SáezBorderías et al., 2009; Lassen et al., 2010) . Interestingly, cytomegalovirus was found to enhance the expression of HLAE, the human counter part of Qa1 (Tomasec et al., 2000) . Factors that affect the expres sion of NKG2A on NK cells and Qa1/HLAE on target cells within the CNS are unknown. In addition to the local inflam matory milieu, CNSinfiltrating NK cells express high levels of nicotinic acetylcholine 2 receptors (unpublished data). Whether these receptors for neuronal or glial transistors, together with other CNS factors, promote expression of NKG2A warrants further investigations. Activationinduced cell death is an important mechanism to contract the T cell compartment in adaptive immune responses. Under several pathological conditions, such as infections or trau matic injury, NK cells readily home to the brain and spinal cord (Shi and Ransohoff, 2009) . Innate NK cells participate in early host defenses and mobilize the adaptive immune system to com bat infectious agents. Once infection is controlled, inflammatory responses driven by microglia and other types of CNSderived APCs must be tapered down to avoid autoimmune responses. By interacting with MHC class I molecules that are constitu tively expressed by microglia during steady state and are lost upon prolonged activation, NK cells can ensure tolerance to self while allowing toxicity toward stressed cells.
Microglia are prone to activation (Hanisch and Kettenmann, 2007) . Microglia in the CNS are activated in EAE even before the arrival of T cells and other types of peripherally derived APCs (Ponomarev et al., 2007) . Future studies will examine whether the temporal activation of microglial cells and other CNSderived APCs underlies their differential expression of Qa1 to better explain why microglia become targets for NK cells during CNS inflammation.
It must be acknowledged that the precise role of microg lia during CNS inflammation is not clear, in part because of technical difficulties in enriching these cells from adult brain tissues. Microglia are capable of performing APC functions upon activation and of priming and inducing final effector T cell functions (Ford et al., 1996; Olson and Miller, 2004; Ponomarev et al., 2005) . Activated microglia are thought to play a role in the onset of both MS in humans and EAE in B6 mice (Ponomarev et al., 2007) . However, recent studies have provided evidence that microglia are less effective than other APCs in the CNS in presenting myelin antigens and in prim ing Th cell responses (Bailey et al., 2007) . This finding was confirmed in the current model (Fig. 5) . We also found that a lack of suppressive effects of NK cells led to an expanded microglia compartment and augmented the capacity of these cells to produce Th17polarizing cytokines, further suggest ing our previous observation that CNSderived APCs, resi dent or immigrant, behave differently in the presence or in the absence of NK cells.
To further investigate the biological consequences of the interactions between CNSresident NK cells, microglia, and autoreactive Th17 cells, we used IL17 / mice, which are relatively resistant to the development of EAE. Depletion of NK cells from IL17 / mice did not significantly alter the EAE phenotype of these animals (Fig. 8 B) . Similarly, injec tion of IL2 complexes had a minimal effect on the severity of EAE in IL17 / mice (unpublished data). Thus, interac tions between NK cells, microglia, and Th17 cells play criti cal roles in determining the phenotype of EAE.
DISCUSSION
Compared with other organ systems, the CNS has several unique properties with respect to immune responses, which includes the spectrum of APCs as well as the neuroimmune microenvironment. Regulatory functions of NK cells in EAE, MS, and other autoimmune diseases have been pro posed, but the exact role of NK cells within the CNS remains elusive. Through a combination of approaches using an NK cell-depleting antibody and blockade of NK cell homing to the CNS via disruption of a chemokine receptor that is criti cal for NK cell recruitment and via expansion of NK cells by IL2 complexes, we provide compelling evidence that NK cells within the target organ critically control the magnitude of local inflammatory and autoimmune responses against myelin antigens in the CNS. The findings presented in this paper support a dominant role for NK cells in controlling autoimmunity in target organs. First, selective blockade of NK cell homing to the CNS was sufficient to induce un abated pathology in MOGprimed mice. Second, the thera peutic effect of IL2 complexes was almost entirely dependent on the NK cells in the CNS. Finally, suppression of myelin reactive Th17 cells (and to some extent Th1 cells) by NK cells was largely restricted to the CNS compartment. Thus, these findings suggest regulatory functions of NK cells within a tar get organ of autoimmunity, which appears to be more impor tant for disease manifestation than the events that occurred in the periphery (Fig. S7) .
The finding that NK cells in the CNS play a more critical role than NK cells in the periphery during CNS inflamma tion strongly suggests the participation of an additional factor that is specific to the CNS. These factors might include CNS Ags, signals generated from neuronal cells (Tracey, 2009) , and CNSderived APCs. APCs present in the CNS, whether resident or recruited from the periphery, include CD11c + DCs, mDCs, CD8 + DCs, astrocytes, and microglia (Olson and Miller, 2004; Greter et al., 2005; Bailey et al., 2007; Weber et al., 2007) . Among the different APCs, we found that NK cells preferentially interacted with microglia. The physi cal proximity of NK cells with microglia, as a result of recip rocal chemoattractions, together with colocalization within inflammatory foci, promoted interactions between these two cell types, and a reduced expression of the MHC class I molecule Qa1 on activated microglia triggered NK cell-mediated cyto toxicity. Altogether, our data suggest that microglia are key targets for NK cells.
CNS disease. For example, daclizumab targets the human IL2 receptor and inhibits MS and autoimmune uveitis disease activities (Rose et al., 2004 (Rose et al., , 2007 Li et al., 2005; Bielekova et al., 2006 Bielekova et al., , 2009 Wynn et al., 2010) . The efficacy of this drug has been linked to the expansion of CD56 bright NK cells (Li et al., 2005; Bielekova et al., 2006 Bielekova et al., , 2009 . Copaxone and Rebif/Avonex (IFNs) also increase NK cell cytotoxic activity (Sand et al., 2009; Vandenbark et al., 2009) and the prevalence of CD56 bright NK cells, respectively. The IL2 complexes used in the current studies not only recapitu late the effects of some of these drugs but also provide mech anistic inputs on the importance of CNS versus peripheral NK cells and the means used by NK cells to protect against disease. The importance of CD94/NKG2Adependent inhi bition of myelinreactive T cells (Lu et al., 2007) and its asso ciation with reduced microglia in the CNS during EAE has been elegantly demonstrated (Leavenworth et al., 2010) . The current study extends this mechanistic explanation for the contact of NK cells with other types of CNSderived APCs. Altogether, these studies provide novel insight into the biology of NK cells in relation to organspecific autoimmu nity and might lead to the design of NK cell-based approaches for intervention in inflammatory and autoimmune disorders of the CNS.
MATERIALS AND METHODS
Mice. Female C57BL/6 (B6, H2 b ) mice were purchased from Taconic, and 2D2 mice (Bettelli et al., 2006a) and IL17 / mice (Komiyama et al., 2006) were provided by V. Kuchroo (Brigham and Women's Hospital and Harvard Medical School, Boston, MA) and Y. Iwakura (University of Tokyo, Tokyo, Japan), respectively. Other mutant mice, including Cx3cr1 GFP/GFP (Cx3cr1 / ; Jung et al., 2000) , Qa1 / , CD1d / , RAG1 / c / , perforin / , and IFN / mice were either available in our colony or pur chased from The Jackson Laboratory. All mutant mice were backcrossed to the B6 background for 8-12 generations and were housed in pathogen free conditions at animal facilities of the Barrow Neurological Institute (Phoenix, AZ) or the Tianjin Neurological Institute (Tianjin, China). All animal studies were approved by Animal Care and Use Committees of the BarrowSt. Joseph and Tianjin Neurological Institute. EAE model. The mouse peptide autoantigen MOG 3555 (MEVGWY RSPFSRVVHLYRNGK) was synthesized (purity > 95%) by Bio Synthesis Inc. To induce acute EAE, B6 mice were injected s.c. in the hind flank with 200 µg MOG 3555 peptide in CFA (BD) containing 500 µg of nonviable dessicated Mycobacterium tuberculosis. On the day of, and 2 d after, immunization, the mice were also inoculated with 200 ng pertussis toxin (List Biological) i.v. The passive transfer EAE model with 2D2 T cells is de tailed in the Fig. 8 legend. In brief, splenocytes from MOG TCR transgenic (2D2) mice were stimulated with 10 µg/ml MOG 3555 for 48 h and then ex panded in 5 ng/ml IL2 and IL7 for 5 d. The lymphoblasts were stimulated with 1 µg/ml of platebound antiCD3 and 1 µg/ml of antiCD28 in the presence of 10 ng/ml IL12 and 25 ng/ml IL18 for 24 h. Depending on the experiments, 2 × 10 5 -10 6 2D2 T cells were transferred into RAG1 / c / mice by i.v. injection. Clinical presentations in both models were assessed as previously described (Huang et al., 2006) .
In vivo antibody and cytokine administration. mAbs directed against mouse NK1.1 (PK136 clone; Koo and Peppard, 1984) , IL2 (S4B6 clone), and CD25 (PC61) were produced from hybridomas (American Type Culture Col lection). Carrierfree recombinant mouse IL2 was purchased from eBioscience. Mouse IgG2a (SigmaAldrich) was used as the isotype control antibody.
NK cell-microglia interactions have a profound impact on myelinreactive Th cells, particularly the Th17 cell subset. In vivo cell transfer experiments demonstrated that NK cells are capable of abolishing the effects of microglia on the trans activation of the Th17 signature transcription factors ROR, ROR, and STAT3. It is generally believed that Th cells complete their differentiation in draining lymph nodes (Banchereau and Steinman, 1998) . However, chronic CNS inflammation leads to neogenesis of lymphoid structures within the CNS (Magliozzi et al., 2007) , which may serve as a structural basis for continued T helper cell differentiation and expansion in this compartment. Participation of microg lia clearly indicates that differentiation of autoreactive Th17 cells in the CNS is substantially different from Th17 cell dif ferentiation in the peripheral lymphoid compartment. The importance of NK cell-microglial cell interactions in disease ex pression during IL2 complex therapy is illustrated by our cell transfer experiments. Our finding that neither antiNK1.1 mAbs nor IL2 complexes significantly altered the course of EAE in IL17 / mice further indicates that myelinreactive Th17 cells are the ultimate targets influenced by interactions between NK cells and microglial cells during CNS inflammation (Fig. 8 B) .
NK cells, as well as microglia, have been frequently shown to induce neurotoxicity (Cardona et al., 2006a,b; Hanisch and Kettenmann, 2007) . One study has suggested that microglial neurotoxicity is accelerated by the absence of CX3CR1 (Cardona et al., 2006b) . Whether lack of CX3CR1 expression, caused by a lack of NK cell recruitment, is responsible for unabated neurotoxicity is unclear. MOGprimed Cx3cr1 / mice exhibited similar disease phenotype to mice depleted of NK cells, suggesting that a lack of NK cells in the CNS, rather than microglial neurotoxicity, is responsible for the disease pheno type. The temporal, spatial, and specific microenvironment of the CNS and the local cytokine milieu may further influence the detrimental or beneficial effects of NK cells and microglia.
In addition to NK cells, other IL2R-bearing cells, including NKT cells, CD4 + CD25 + Foxp3 + regulatory T cells, and CD8 + T cells with a memory phenotype, are also expanded, at various degrees, by IL2 complexes. Thus, they might as well contribute to disease protection. Although the regulatory functions of CD8 + T cells are less well characterized than those of T reg cells and NKT cells, emerging evidence indicates that a subpopulation of CD8 + T cells can suppress CD4 + T cells (Lu et al., 2008) , and mice lacking this CD8 + T cell population can develop exagger ated immune responses to autoantigens (Hu et al., 2004) . These cells recognize Qa1 and might use similar mechanisms to NK cells to suppress the functions of microglia (and/or other CNS derived APCs) or CD4 + T cells, as previously suggested (Lu et al., 2008) . Indeed, in our system the IL2-expanded CD8 + T cells also lysed microglia, albeit at lower efficiency than NK cells, and IL2 complexes partially lost their therapeutic effects in CD8 / mice. Whether and how these CD8 + T cells act on other CNSderived APCs or myelinreactive T cells directly or indirectly warrants further investigations. Finally, our findings have important implications for understanding the efficacy of some drugs currently used in between the 30-70% percoll interface was collected as the CNS mononu clear cells for staining. APCs (mDC, CD45 hi CD3  CD11b + F4/80 + CD11c + ; pDC, CD11b  CD11c + B220 + PDCA1 + CD8 + or CD8  and CD11b  C D11c + B220  CD8 + CD205 + or CD205  CD8 + DCs; astrocytes, GFAP) were isolated and enriched as previously described with modification (Bailey et al., 2007; Liu et al., 2007) . For cytokine induction, the isolated CNS derived APCs were cultured with 3 ng/ml GMCSF (R&D Systems). 1 µg/ml of soluble CD40L (R&D Systems) was added. After 48 h, IL1, IL6, IL21, TGF, and IL23 in the supernatant was assayed by ELISA according to the manufacturer's instructions (eBioscience).
Microglial cell isolation. We used mice in which the CX3CR1 gene was re placed with a cDNA encoding GFP, such that Cx3cr1 +/ (Cx3cr1 +/GFP ) mice express the GFP reporter in cells that retain their receptor function, whereas Cx3cr1 / (Cx3cr1 GFP/GFP ) cells are also labeled and lack CX3CR1 expression (Cardona et al., 2006a,b) . Because CX3CR1GFP reporter mice can exclusively identify microglia in vivo in the CNS, the Cx3cr1 +/ mice permitted us to iso late and purify these cells ex vivo (Cardona et al., 2006a,b) . Before removal of CNS tissues, perfusion was routinely performed to exclude contamination of peripherally arrived cells also expressing CX3CR1 (also GFP + ).
Construction of lentiviral vectors encoding Qa-1 and transduction into microglia. Fulllength Qa1 cDNA was amplified by RTPCR from RNA isolated from splenocytes of B6 mice. After verification of the sequence, cDNA was ligated into the PlvxDsRedMonomerC1 vector (Takara Bio Inc.) replacing the red protein coding sequence of DsRed. The recombinant lentivirus was produced by LentiX 293T Cells (Takara Bio Inc.) with LentiX HT Packaging System (Takara Bio Inc.). Virus was col lected 72 h after transfection and titers were up to 5-8 × 10 8 infectious units/ml. Microglia purified from B6 background Qa1-deficient mice were infected with virus in 24well plates precoated with 20 µg/ml polyLlysine for 16 h. The viruscontaining transduction medium was then replaced with fresh growth medium, the incubation of the cells continued for 24 h at 37°C and 5% CO 2 .
NK cell cytotoxicity assays. NK cell cytotoxicity was assessed by the chromium release assay using 51 Crlabeled YAC1 mouse lymphoma cell line, microglia, and other types of APCs (Shi et al., 2000) . Freshly purified NK cells were incubated with 51 Crlabeled target cells (5 × 10 3 ) at various effector cell/target cell ratios. After 4 h of incubation, the supernatants were harvested and 51 Cr release was measured with a  counter (PerkinElmer). The percent age of specific lysis was calculated according to the following formula: (ex perimental release  spontaneous release)/(maximum release  spontaneous release) × 100. Cytotoxicity assay was done in triplicate (Shi et al., 2000) .
A rapid elimination assay was used to determine whether NK cells can eliminate microglia in vivo, as previously described (Assarsson et al., 2004) . 5 × 10 5 51 Crlabeled microglia were microinjected into the brain of the re cipient mice. The CNS tissues (brain and spinal cord) were removed after 8 h and counted in a gamma radiation counter. The percentage of remain ing radioactivity was determined as follows: (organ  background/dose of cells  background) × 100. Radioactivity recovered from control mice and experimental mice was an accurate measurement of intact microglia remain ing in the CNS.
Cell migration assay. Chemotaxis of microglia toward chemokines pro duced by CNSderived NK cells was tested in vitro using a polycarbonate filter microchamber filtration system (Neuro Probe) with small pores (3 µm). 2 × 10 5 microglial cells were added to the upper well of the upper compart ment in the presence of 1 nM PMA. The lower compartment was filled with 300 µl of medium containing no chemotactic supplement, recombinant 10 ng/ml MIP1 (R&D Systems), or supernatants collected from purified microglia cells stimulated for 24 h with 1 nM PMA with or without 5 µg/m of anti-MIP1 (R&D Systems). Chemotaxis of CNSderived NK cells to ward chemokines produced by microglia was tested using the same system. In brief, 2 × 10 5 NK cells were seeded into the upper compartment of the For depletion of NK1.1 + cells or CD25 + cells in vivo, 100 µg of anti NK1.1 mAb or antiCD25 mAb was injected i.p. into each mouse at day 2 after immunization. Every 5 d thereafter, 50 µg antiNK1.1 mAb or anti CD25 were injected i.p. until termination of experiments (Shi et al., 2000; Liu et al., 2005) . Depletion of NK1.1 + and CD25 + cells was confirmed by flow cytometry and was always >90%.
For the preparation and administration of IL2 and anti-IL2 mAb complexes (referred to as IL2 complexes), equal volumes of 30 µg/ml rIL2 and 300 µg/ml of anti-mouse IL2 mAb in PBS were mixed in vitro and 100 µl of this solution was injected i.p. into each mouse, resulting in IL2 complexes formed by 1.5 µg rIL2 with 15 µg of anti-IL2 mAb per mouse, as modified from a published protocol (Boyman et al., 2006) . As controls, animals were treated with rIL2 or anti-IL2 mAb only and received 200 µl IgG with the same amount of either rIL2 or anti-IL2 mAb as for the IL2 complexes. Additional control mice received equivalent doses of purified normal rat isotype IgG2a. Injections were repeated two times every week starting on the same day of MOG 3555 immunization (day 0) until termina tion of the experiment.
Intracerebral injection. Mice were anesthetized with 87 mg/kg ketamine and 13 mg/kg xylazine and placed in the stereotaxic apparatus (Kopf Instruments). Microglia injection was performed as previously described (Cardona et al., 2006b) . Implantation was performed as previously described with some modifi cations (see Supplemental material; Abizaid et al., 2006; Hemsley et al., 2009 ).
Neuropathology and neuroimaging. For study of inflammation, GFP + microglia morphology, cellular colocalization, and dihydroethidium (DHE) oxidation in mice brain, mice received DHE i.p. and were sacrificed by pentobarbital injection 18 h later and perfused by intracardiac puncture with 50 ml of cold PBS. Brains and spinal cords were removed, frozen immedi ately, and then stored at 80°C. 10-30µm serial cryosections were prepared. Three serial sections were stained with H&E, luxol blue, PE antiNK1.1 (PK136), or antiNKp46 (29A1.4) antibodies. All images were captured with a confocal microscope (LSM 710; Carl Zeiss, Inc.) with Microscope image acquisition software.
For imaging of ROS generation in brain, bioluminescence images in live mice were captured using the Xenogen IVIS200 imager (Caliper Life Sciences) at several time points after injection of 27 mg/kg DHE (Invitro gen). A region of interest tool was used to measure the fluorescent intensity. Data were collected as photons per second per centimeter squared using the Living Image software (Caliper Life Sciences).
MRI was performed using a 7T small animal, 30cm horizontalbore magnet, and BioSpec Avance III spectrometer (Bruker) with a 116mm high power gradient set (600 mT/m) and a 72mm wholebody mouse transmit/ surface receive coil configuration. Axial and coronal T1weighted (MSME; echo time [TE] 10.5 ms, repetition time [TR] 322 ms, 0.5mm slice thick ness, matrix 256 × 256, field of view [FOV] 2.8 cm, eight averages, 40 coro nal slices, scan time 22 min, and 20 axial slices, scan time 16 min) and fatsuppressed turbo spin echo T2weighted (RARE; TE1 14.5 ms, TE2 65.5 ms, TR 4,500 ms, 0.5mm slice thickness, Matrix 256 × 256, FOV 2.8 cm, eight averages, 40 coronal slices, scan time 28 min, and 20 axial slices, scan time 28 min) images were acquired, covering the volume of brain from the olfactory bulb/frontal lobe fissure to the cervical spinal cord. MRI data were analyzed using the MEDx3.4.3 software package (Medical Numerics) on a LINUX workstation.
Isolation of mononuclear cells from the CNS. For CNSinfiltrating mononuclear cell isolation, at day 11 after EAE induction mice were sacri ficed and perfused with PBS delivered transcardially to eliminate contami nating blood cells in the CNS. Fresh brain and/or spinal cords were removed from five to six mice, cut into small pieces, and digested in 10 mM Hepes/ NaOH buffer containing 1 mg/ml collagenase for 1 h at 37°C. Tissues were homogenized with a syringe, filtered through a 70µM cell strainer to obtain a single cell suspension, and centrifuged. Cell pellets were resuspended in 30% percoll and centrifuged against 70% percoll. The cell monolayer kit (QIAGEN), in accordance with the manufacturer's instructions. The following primers were used: IL17 forward, 5CCTCCAGAATGT GAAGGTCA3; IL17 reverse, 5CTATCAGGGTCTTCATTGCG3; IFN forward, 5AGCTCTTCCTCATGGCTGTT3; IFN reverse, 5TTTGCCAGTTCCTCCAGATA3; ROR forward, 5TCTCCCT GCGCTCTCCGCAC3; ROR reverse, 5TCCACAGATCTTGCAT GGA3; ROR forward, 5 CCCCCTGCCCAGAAACACT3; ROR reverse, 5GGATGCCCCCATTCACTTACTTCT3; hypoxanthine guanine phosphoribosyltransferase (HPRT) forward, 5AGCCTAAGATGAG CGCAAGT3; and HPRT reverse, 5TTACTAGGCAGATGGCCACA3. The HPRT gene was amplified and served as an endogenous control. 1 µl of firststrand cDNA product was amplified with platinum Taq polymerase (Invitrogen) and genespecific primer pairs. Each sample was assayed in triplicate and experiments were repeated twice. The relative amounts of mRNA were calculated by plotting the Ct (cycle number), and mean relative expression was determined by the 2 Ct comparative method.
Online supplemental material. Fig. S1 shows approaches to study NK cells during CNS inflammation. Fig. S2 shows the effect of antiNK1.1 mAb on the development and progression of EAE in B6 mice and in CD1d / mice. Fig. S3 shows global alteration of Th17polarizing cytokines and other inflammatory mediators in mice when NK cells are manipulated. Fig. S4 shows the impact of antiNK1.1 mAb or IL2 C injection on CD8 + T cell responses. Fig. S5 shows effects of IL2 immune complexes on NK (CD3  NK1.1 + ), NKT (CD3 + NK1.1 + ), CD4 + , CD4 + CD25 + , and CD4 + CD25 + T cells. Fig. S6 shows the contributions of IL2 receptor-bearing NKT cells, T reg cells, and CD8 + cells to protection against EAE conferred by IL2 complexes. Fig. S7 shows NK cell-mediated inhibition of Th17 cells and autoimmunity in the CNS. Table S1 shows the effects of IL2 complexes on induction and maintenance of NK cells, as well as clinical features of EAE. Online supplemental material is available at http://www.jem.org/ cgi/content/full/jem.20092749/DC1.
Cell proliferation (CFSE and BrdU) assays. For CFSE labeling assays, single cell suspensions (4 × 10 7 cells) were prepared and labeled with 0.5 µM CFSE at 37°C for 10 min. Subsequently, when cells were cultured, levels of CFSE staining declined with each cell division, allowing for cell proliferation to be monitored. Cells labeled with or without CFSE were incubated at 37°C for 3 d in roundbottom plates (2 × 10 6 cells/well) with or without antigens (10 µg/ml MOG 3555 ). After harvesting, cells were stained for sur face markers with fluorochromeconjugated monoclonal antibodies, in cluding anti-CD3PE/Cy5 (17A2), anti-CD4allophycocyanin/Cy7 (GK1.5), and anti-CD8PE/Cy7 (53-6.7; BD). Isotypematched monoclonal anti bodies were used as controls.
For in vivo BrdU incorporation assays, mice were injected with 1.0 mg BrdU (BD) solution. After 18-24 h, single cell suspensions were prepared from spleens and/or thymuses and surface stained with PECy7-labeled anti CD4 (GK1.4), allophycocyaninlabeled antiCD25 (7D4), and FITClabeled antiBrdU mAb according to the manufacturer's instructions (BD). Samples were analyzed on a FACSAria flow cytometer (BD) using Diva software.
FACS analysis.
Single cell suspensions (10 6 cells) were prepared from spleen or lymph nodes or CNS and stained with fluorochromeconjugated antibodies. All antibodies were purchased from BD, eBioscience, or Santa Cruz Biotechnology, Inc. unless otherwise indicated. Antibodies were di rectly labeled with one of the following fluorescent tags: FITC, PE, PerCP, allophycocyanin, PC5, or PC7. The following antibodies were used: CD3 (1452C11), CD4 (GK1.4), CD8 (53-6.7), CD11b (M1/70), CD11c (HL3), CD19 (1D3), CD25 (7D4), CD38 (90), CD138 (281-2), STAT3 (pY705), Qa1 (6A8.6F10), NKG2D (CX5), NKp46 (29A1.4), F4/80 (BM8), CD205 (205yekta), and NK1.1 (PK136). Flow cytometric data were collected on a FACSAria flow cytometer and analyzed with Diva software. Isotype matched negative control mAbs were used for all stains. To determine the percentage of cells producing selected cytokines, values obtained with iso type controls were subtracted from those with specific mAb.
Cytokine quantification. For intracellular cytokine staining, single cell suspensions (30 × 10 6 cells) were prepared and incubated at 37°C for 4 d in roundbottom plates (2 × 10 6 cells/well) with or without antigens (10 µg/ml MOG 3555 or 5 µg/ml Con A) and stimulated with a mixture of 20 ng/ml PMA, 1 µg/ml ionomycin, and 5 µg/ml brefeldin A for another 5 h at 37°C. After harvesting, cells were stained for surface markers, fixed and permeabilized with the Cytofix/Cytoperm kit (BD), and then stained with anti-IFN and anti-IL17 mAb conjugated with Alexa Fluor 647 or PE. For intracellular Foxp3 expression, fresh cells were stained for surface markers with anti-CD4FITC (H129.19) and anti-CD25allophycocyanin (PC61.5) for 15 min at 4°C, fixed, permeabilized, and then stained with anti-Foxp3PE (FJK16s; eBioscience). All samples were analyzed on a FACSAria using Diva software. ELISA with OptEIA kits (BD) was per formed for assessment of cytokine release from microglia and IL2 complex expanded NK cells.
qRT-PCR. Total RNA was extracted from cell suspensions of spinal cords using TRIzol (Invitrogen). Firststrand cDNA of each sample was syn thesized using a reverse transcription kit (Invitrogen). RTPCR was per formed as previously described, using an ABI Prism 7900HT sequence system (Applied Biosystems) with the QuantiTect SYBR Green PCR
